APA (7th ed.) Citation

MS, L., P, B., N, A., L, B., MO, S., L, D., & JB, J. (2020). The DaBlaCa-13 Study: Short-term, Intensive Chemoresection Versus Standard Adjuvant Intravesical Instillations in Non-muscle-invasive Bladder Cancer-A Randomised Controlled Trial. European urology, 78(6), 856. https://doi.org/10.1016/j.eururo.2020.07.009

Chicago Style (17th ed.) Citation

MS, Lindgren, Bue P, Azawi N, Blichert-Refsgaard L, Sundelin MO, Dyrskjøt L, and Jensen JB. "The DaBlaCa-13 Study: Short-term, Intensive Chemoresection Versus Standard Adjuvant Intravesical Instillations in Non-muscle-invasive Bladder Cancer-A Randomised Controlled Trial." European Urology 78, no. 6 (2020): 856. https://doi.org/10.1016/j.eururo.2020.07.009.

MLA (9th ed.) Citation

MS, Lindgren, et al. "The DaBlaCa-13 Study: Short-term, Intensive Chemoresection Versus Standard Adjuvant Intravesical Instillations in Non-muscle-invasive Bladder Cancer-A Randomised Controlled Trial." European Urology, vol. 78, no. 6, 2020, p. 856, https://doi.org/10.1016/j.eururo.2020.07.009.